| MDVYX | VIVIX | MDVYX / VIVIX | |
| Total Expense Ratio | 0.84 | 0.04 | 2,100% |
| Annual Report Gross Expense Ratio | 0.84 | 0.04 | 2,100% |
| Fund Existence | 21 years | 27 years | - |
| Gain YTD | -13.905 | 9.429 | -147% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 444M | 208B | 0% |
| Annual Yield % from dividends | 1.73 | 2.10 | 83% |
| Returns for 1 year | -24.29 | 4.75 | -512% |
| Returns for 3 years | -31.02 | 30.34 | -102% |
| Returns for 5 years | -17.15 | 62.26 | -28% |
| Returns for 10 years | -32.74 | 123.23 | -27% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IMST | 19.73 | 1.09 | +5.82% |
| Bitwise MSTR Option Income Strategy ETF | |||
| LFSC | 34.06 | 0.07 | +0.20% |
| F/m Emerald Life Sciences Innovation ETF | |||
| BSCW | 20.84 | 0.02 | +0.10% |
| Invesco BulletShares 2032 Corp Bd ETF | |||
| DUBS | 36.48 | -0.18 | -0.49% |
| Aptus Large Cap Enhanced Yield ETF | |||
| RSEE | 32.62 | -0.32 | -0.98% |
| Rareview Systematic Equity ETF | |||